ArticleOxford medical case reports2019

A case report of successful treatment of high-output heart failure secondary to hereditary haemorrhagic telangiectasia with bevacizumab.

Mark Flower et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.